In case you missed! Also for you to make a note!
$Adaptimmune Therapeutics(ADAP.US$ Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review ● If approved, afami-cel will be the first engineered T-cell therapy for solid tumors and the first effective treatment option for synovial sarcoma in more than a decade PHILADELPHIA and OXFORD, UK, January, 31, 2024 – Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its Biologics License Application (BLA) for afami-cel, an investigational engineered T-cell therapy for advanced synovial sarcoma. The application has a Prescription Drug User Fee Act (PDUFA) target action date of August, 4, 2024.![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
JESSE JAMES8832 : could be big
TrytosaveabitOP JESSE JAMES8832: It surely could! That’s why I’m posting so far out! So people can decide whether to wait until that day and see? Or be looking for a good place to buy in for a swing trade! Either way it’s been on a beautiful uptrend since mid/late December with the exception of a few days for RSI to cool off a bit! Hehehe